Reassessment of deferrals for tattooing and piercing.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMID 19171003)

Published in Transfusion on January 02, 2009

Authors

Mindy Goldman1, Guoliang Xi, Qi-Long Yi, Wenli Fan, Sheila F O'Brien

Author Affiliations

1: Canadian Blood Services Donor and Transplantation Services, University of Ottawa, Ottawa, Ontario, Canada. mindy.goldman@blood.ca

Articles by these authors

Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol (2005) 2.42

p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation. Blood (2004) 1.78

Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol (2003) 1.63

Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy. Am Heart J (2007) 1.62

Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer. J Thorac Cardiovasc Surg (2007) 1.58

Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. CMAJ (2003) 1.51

Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. Transfusion (2007) 1.47

The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant. Br J Haematol (2004) 1.45

Effect of platelet additive solution on bacterial dynamics and their influence on platelet quality in stored platelet concentrates. Transfusion (2010) 1.42

Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome. Leuk Res (2004) 1.42

Dietary patterns and risk of prostate cancer in Ontario, Canada. Int J Cancer (2005) 1.26

Assessing cognitive function in cancer patients. Support Care Cancer (2006) 1.25

Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study. J Am Soc Nephrol (2003) 1.18

Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis. Cancer (2010) 1.14

Declining hepatitis C rates in first-time blood donors: insight from surveillance and case-control risk factor studies. Transfusion (2008) 1.11

Donor understanding and attitudes about current and potential deferral criteria for high-risk sexual behavior. Transfusion (2011) 1.11

Clinical relevance of cytogenetic abnormalities at diagnosis of acquired aplastic anaemia in adults. Br J Haematol (2006) 1.07

Validation and implementation of a new hemoglobinometer for donor screening at Canadian Blood Services. Transfusion (2012) 1.03

Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection? Lung Cancer (2005) 1.00

Screening of Canadian Blood Services donors for severe immunoglobulin A deficiency. Transfusion (2010) 0.94

Epidemiology of hepatitis B in Canadian blood donors. Transfusion (2008) 0.94

Mapping the connections between education and dementia. J Clin Exp Neuropsychol (2007) 0.94

Iron deficiency in Canadian blood donors. Transfusion (2013) 0.92

Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study. Am J Kidney Dis (2003) 0.91

A visual approach to providing prognostic information to parents of children with retinoblastoma. Psychooncology (2009) 0.91

Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. Transfusion (2007) 0.90

Prognostic significance of trisomy 4 as the sole cytogenetic abnormality in acute myeloid leukemia. Leuk Res (2003) 0.88

Plasma organochlorine levels and prostate cancer risk. J Expo Sci Environ Epidemiol (2009) 0.87

Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease. Kidney Int Suppl (2004) 0.87

A third course of anti-thymocyte globulin in aplastic anaemia is only beneficial in previous responders. Br J Haematol (2005) 0.86

Primary radical external beam radiotherapy of rectal adenocarcinoma: long term outcome of 271 patients. Radiother Oncol (2005) 0.86

An analysis of the bias in red blood cell hemolysis measurement using several analytical approaches. Clin Chim Acta (2012) 0.86

Risk of a right pneumonectomy: role of bronchopleural fistula. Ann Thorac Surg (2005) 0.86

Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy. Cancer (2005) 0.85

Chronic disease status, self-perceived health and hospital admissions are important predictors for having a flu shot in Canada. Vaccine (2007) 0.85

Face-to-face interviewing in predonation screening: lack of effect on detected human immunodeficiency virus and hepatitis C virus infections. Transfusion (2006) 0.85

Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing. Transfusion (2008) 0.84

Frequency and risk factors for donor reactions in an anonymous blood donor survey. Transfusion (2012) 0.84

Transfusion and risk of infection in Canada: Update 2012. Paediatr Child Health (2012) 0.84

Quality of red blood cells washed using the ACP 215 cell processor: assessment of optimal pre- and postwash storage times and conditions. Transfusion (2013) 0.83

Donor research: the foundation for a healthy blood supply. Transfusion (2006) 0.83

Frequency of severe allergies in blood donors. Transfusion (2011) 0.82

Selective testing for Trypanosoma cruzi: the first year after implementation at Canadian Blood Services. Transfusion (2012) 0.82

Evaluating the 4-hour and 30-minute rules: effects of room temperature exposure on red blood cell quality and bacterial growth. Transfusion (2012) 0.82

Biofilm-forming skin microflora bacteria are resistant to the bactericidal action of disinfectants used during blood donation. Transfusion (2014) 0.81

Influence of one human leukocyte antigen mismatch on outcome of allogeneic bone marrow transplantation from related donors. Hematology (2003) 0.81

Predictors for erectile dysfunction among diabetics. Diabetes Res Clin Pract (2005) 0.81

Clinical outcome of frequent exposure to Torque Teno virus (TTV) through blood transfusion in thalassemia patients with or without hepatitis C virus (HCV) infection. J Med Virol (2008) 0.81

Predictive ability of sequential surveys in determining donor loss from increasingly stringent variant Creutzfeldt-Jakob disease deferral policies. Transfusion (2006) 0.80

Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies. Transfusion (2009) 0.80

Evaluation of selective screening of donors for antibody to Trypanosoma cruzi: seroprevalence of donors who answer "no" to risk questions. Transfusion (2013) 0.79

The donor health assessment questionnaire: potential for format change and computer-assisted self-interviews to improve donor attention. Transfusion (2007) 0.78

The Canadian donor health assessment questionnaire: can it be improved? Transfusion (2006) 0.77

Quality of red blood cells washed using an automated cell processor with and without irradiation. Transfusion (2013) 0.77

CD7 expression predicts poor disease free survival and post-remission survival in patients with acute myeloid leukemia and normal karyotype. Leuk Res (2006) 0.77

Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop. Transfusion (2012) 0.77

Transfusion reactions: a comparative observational study of blood components produced before and after implementation of semiautomated production from whole blood. Transfusion (2012) 0.77

Predictors of antiviral therapy in a post-transfusion cohort of hepatitis C patients. Can J Gastroenterol (2006) 0.77

Breast tissue organochlorine levels and metabolic genotypes in relation to breast cancer risk Canada. Cancer Causes Control (2004) 0.76

Process improvement by eliminating mixing of whole blood units after an overnight hold prior to component production using the buffy coat method. J Blood Transfus (2013) 0.75

A predonation screening question for occupational exposure to simian foamy virus: a preliminary donor survey in Canada. Transfusion (2007) 0.75

Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay. Transfusion (2009) 0.75

Reduced risk of hospitalization associated with influenza vaccination in Canada. Vaccine (2010) 0.75

Donor deferral policies for men who have sex with men: where are we today? Curr Opin Hematol (2016) 0.75

[Effects of rhizosphere CO2 concentration on potato growth]. Ying Yong Sheng Tai Xue Bao (2005) 0.75